Not applicableNot Yet RecruitingNCT07204600What this trial is testingPrevalence & Risk Factors of De Novo (MASLD) Post Liver TransplantWho this might be right forPost Liver Tranзplant Assiut University 100
Not applicableStudy completedNCT05808192What this trial is testingDe Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression WithdrawalWho this might be right forSingle Transplant5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS University of Rome Tor Vergata 92
Post-approval studies (Phase 4)Ended earlyNCT01371344What this trial is testingA Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft RecipientsWho this might be right forHeart TransplantationKidney TransplantationLiver Transplantation Astellas Pharma Europe Ltd. 47
Post-approval studies (Phase 4)Study completedNCT01339468What this trial is testingAssess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver TransplantationWho this might be right forLiver Transplantation Astellas Pharma Inc 100
Testing effectiveness (Phase 2)Study completedNCT00772148What this trial is testingPharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant PatientsWho this might be right forLiver Failure Veloxis Pharmaceuticals 58
Large-scale testing (Phase 3)Ended earlyNCT00284921What this trial is testingMYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C PositiveWho this might be right forDe Novo Kidney Transplant Novartis Pharmaceuticals 60
Not applicableStudy completedNCT01467011What this trial is testingMyfortic, Prograf, and Corticosteroids in de Novo Liver TransplantationWho this might be right forEnd Stage Liver Disease R. Mark Ghobrial, MD 25